跳至主要内容
临床试验/NCT01138852
NCT01138852已完成4 期

Ampicillin / Sulbactam Versus Cefuroxime as Antimicrobial Prophylaxis for Cesarean Section: a Randomized Study

Attikon Hospital0 个研究点目标入组 176 人开始时间: 2004年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
176

研究概览

简要总结

The efficacy and safety of a single dose of ampicillin/sulbactam compared to a single dose of cefuroxime at cord clamp for prevention of postcesarean infectious morbidity has not been assessed.

Women scheduled for cesarean delivery were randomized to receive a single dose of either 3g of ampicillin-sulbactam or 1.5g of cefuroxime intravenously, after umbilical cord clamping. An evaluation for development of postoperative infections and risk factor analysis was performed.

详细描述

The efficacy and safety of a single dose of ampicillin/sulbactam compared to a single dose of cefuroxime at cord clamp for prevention of postcesarean infectious morbidity has not been assessed.

The investigation was designed to evaluate the efficacy and safety of a single dose of ampicillin/sulbactam 3g compared to a single dose of cefuroxime 1.5g in preventing postoperative morbidity. The primary outcome was development of an infection either at the surgical site or elsewhere e.g. urinary tract infection.

A prospective randomized controlled study was performed from July 2004 to December 2008 in one major tertiary care hospital in Athens Greece. All patients undergoing a cesarean delivery were eligible.Patients were randomly assigned to receive either 1.5g of cefuroxime, or 3g of ampicillin/ sulbactam intravenously after the time the umbilical cord was clamped.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

性别
Female
接受健康志愿者

入选标准

  • All patients undergoing a cesarean delivery were eligible.

排除标准

  • Patients with known hypersensitivity to penicillin or cephalosporins.
  • Patients who required concomitant antibiotic therapy during surgery.
  • Patients who have received antibiotics during the 72 hours immediately preceding their enrollment.
  • Patients whose postpartum fever was clearly associated with other known causes.

研究组 & 干预措施

ampicillin-sulbactam

Experimental

This is the drug used to prevent post-cesarean infection

干预措施: Ampicillin-sulbactam (Drug)

ampicillin-sulbactam

Experimental

This is the drug used to prevent post-cesarean infection

干预措施: Cefuroxime (Drug)

cefuroxime

Active Comparator

This drug was compared to ampicillin sulbactam for prevention of infection

干预措施: Ampicillin-sulbactam (Drug)

cefuroxime

Active Comparator

This drug was compared to ampicillin sulbactam for prevention of infection

干预措施: Cefuroxime (Drug)

研究者

发起方
Attikon Hospital
申办方类型
Other

相似试验